Thursday, December 1, 2016

ADI’s MERS-CoV ELISA kits used in patient study published in Nature journal

A group of renowned medical scientists from South Korea has published the findings of a study performed on MERS patients in Nature journal. They used Anti-MERS-CoV S1 ELISA kit obtained from Alpha Diagnostic International (ADI) to measure specific antibody responses to the MERS-CoV spike protein S1 domain. The study concluded that the correlation of the virological and immunological responses with disease severity and mortality, as well as their responses to current antiviral therapy, may have prognostic significance during the early phase of MERS.

Title of article:
Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients
representing a broad spectrum of disease severity.
Chan-Ki Min*, Shinhye Cheon*, Na-Young Ha*, Kyung Mok Sohn*, Yuri Kim, Abdimadiyeva Aigerim, Hyun Mu Shin, Ji-Yeob Choi, Kyung-Soo Inn, Jin-Hwan Kim, Jae Young Moon, Myung-Sik Choi1, Nam-Hyuk Cho & Yeon-Sook Kim

ADI MERS-CoV products –

Alpha Diagnostic International, Inc has been at the forefront in developing and marketing innovative research and detection kits for both human and animal diseases as well as vaccines validations.

Contact us –    T(800) 786 5777  F(210) 561 9544

No comments:

Post a Comment